is

acto

ntervention Trial.A

Epidemiol.

;

:

–

Thompso

G,Kienas

,Pyk

D,etal.Hemostaticfactorsandthe risk of myocardial infarction or sudden death in patients with an- ginapectoris.Europea

oncerte

ctiono

hrombosisan

is- abilitie

ngin

ectori

tud

roup.NEng

Med.

;

:

–

L

M,Vilce

Interleukin

:amultifunctionalcytokineregulating immunereactionsandtheacutephaseproteinresponse.La

nvest.

;

:

–

Gauldie J, Richards C, Northemann W, et al. IFN beta

/BSF

/IL-

is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes. Ann N Y Acad Sci.

;

:

–

Interleukin 6 is a potent stimulator of C-reactive pro- tein in the liver and acts synergistically with glucocorti- coids to induce the synthesis of other acute phase proteins by the liver. In addition, glucocorticoids inhibit the pro- duction of interleukin 6 when administered in pharma- cological amounts or when present at high levels (23,24). However, in physiological circumstances, the stimulatory effect of glucocorticoids on interleukin 6 is minor or even absent (23). The variation in basal cortisol levels in carri- ers and noncarriers of the ER22/23EK polymorphism is likely to be within the physiological range because corti- sol levels did not differ significantly by genotype. How- ever, in general, the biological response of a target cell to a hormone is determined by several factors, including the concentration of the hormone, the concentration of re- ceptors, and the affinity of the hormone-receptor inter- action. For example, glucocorticoids also upregulate the interleukin 6 receptor (25), by which they can influence the biological effects of interleukin 6. The ER22/23EK polymorphism, which is associated with relative resis- tance to the effects of glucocorticoids, might result in a lesser degree of upregulation of the interleukin 6 recep- tor. Thus, although there were no differences in circulat- ing interleukin 6 concentrations, the ER22/23EK poly- morphism might result in a decreased stimulation of C-reactive protein production. In addition, C-reactive

Glucocorticoid Receptor Polymorphism/van Rossum et al

Hak AE, Stehouwer CD, Bots ML, et al. Associations of C-reactive proteinwithmeasuresofobesity,insulinresistance,andsubclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol.

;

:

–

Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive pro- teininhealthysubjects:associationswithobesity,insulinresistance, andendothelialdysfunction:apotentialroleforcytokinesoriginat- ing from adipose tissue? Arterioscler Thromb Vasc Biol.

;

:

–

Visser M, Bouter LM, M

uillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA.

;

:

–

Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adi- pose tissue releases interleukin-

, but not tumor necrosis factor- alpha, in vivo. J Clin Endocrinol Metab.

;

:

–

D

ijk R, Michelson D, Karp B, et al. Exercise and circadian rhythm-inducedvariationsinplasmacortisoldifferentiallyregulate interleukin-

beta (IL-

beta), IL-

, and tumor necrosis factor-al- pha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-

J Clin Endocrinol Metab.

;

:

–

Rock CS, Coyle SM, Keogh CV, et al. Influence of hypercortisol- emia on the acute-phase protein response to endotoxin in humans. Surgery.

;

:

–

Snyers L, De Wit L, Content J. Glucocorticoid up-regulation of high-affinity interleukin

receptors on human epithelial cells. Proc Natl Acad Sci U S A.

;

:

–

Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose

Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin

in unstable angina. Circulation.

;

:

–

Torre-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol.

;

:

–

Gotfredsen A, Jensen J, Borg J, Christiansen C. Measurement of lean body mass and total body fat using dual photon absorptiom- etry. Metabolism.

;

:

–

Guralnik JM, Seeman TE, Tinetti ME, et al. Validation and use of performance measures of functioning in a non-disabled older population:Ma

rthurstudiesofsuccessfulaging.Aging(Milano).

;

:

–

Pincus T, Summey JA, Soraci SA Jr, et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Healt

ssessmen

uestionnaire.Arthriti

heum.

;

:

–

Koper JW, Stolk RP, de Lange P, et al. Lack of association between fivepolymorphismsinthehumanglucocorticoidreceptorgeneand glucocorticoid resistance. Hum Genet.

;

:

–

Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterio- scler Thromb Vasc Biol.

;

:

–

Rattazzi M, Puato M, Faggin E, et al. C-reactive protein and inter- leukin

in vascular disease: culprits or passive bystanders? J Hyper- tens.

;

:

–

Frohlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome: a population- based study. Diabetes Care.

;

:

–